Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

K. Kuus-Reichel, L. S. Grauer, L. M. Karavodin, C. Knott, M. Krusemeier, Neil Elliot Kay

Research output: Contribution to journalArticle

150 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)365-372
Number of pages8
JournalClinical and Diagnostic Laboratory Immunology
Volume1
Issue number4
StatePublished - Jul 1994
Externally publishedYes

Fingerprint

Anti-Idiotypic Antibodies
Animals
Monoclonal Antibodies
Therapeutics

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies? / Kuus-Reichel, K.; Grauer, L. S.; Karavodin, L. M.; Knott, C.; Krusemeier, M.; Kay, Neil Elliot.

In: Clinical and Diagnostic Laboratory Immunology, Vol. 1, No. 4, 07.1994, p. 365-372.

Research output: Contribution to journalArticle

Kuus-Reichel, K, Grauer, LS, Karavodin, LM, Knott, C, Krusemeier, M & Kay, NE 1994, 'Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?', Clinical and Diagnostic Laboratory Immunology, vol. 1, no. 4, pp. 365-372.
Kuus-Reichel, K. ; Grauer, L. S. ; Karavodin, L. M. ; Knott, C. ; Krusemeier, M. ; Kay, Neil Elliot. / Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?. In: Clinical and Diagnostic Laboratory Immunology. 1994 ; Vol. 1, No. 4. pp. 365-372.
@article{be5722db855f47f59612cea4a2fff51e,
title = "Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?",
author = "K. Kuus-Reichel and Grauer, {L. S.} and Karavodin, {L. M.} and C. Knott and M. Krusemeier and Kay, {Neil Elliot}",
year = "1994",
month = "7",
language = "English (US)",
volume = "1",
pages = "365--372",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

AU - Kuus-Reichel, K.

AU - Grauer, L. S.

AU - Karavodin, L. M.

AU - Knott, C.

AU - Krusemeier, M.

AU - Kay, Neil Elliot

PY - 1994/7

Y1 - 1994/7

UR - http://www.scopus.com/inward/record.url?scp=0028468516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028468516&partnerID=8YFLogxK

M3 - Article

C2 - 8556470

AN - SCOPUS:0028468516

VL - 1

SP - 365

EP - 372

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 4

ER -